CMS Releases 2024 HIT Monitoring Report
CMS released its annual monitoring report[link] on the Medicare Part B Home Infusion Therapy (HIT) Services benefit showing that both provider participation and beneficiary utilization have declined over the past year.
NHIA Releases 2024 Commercial Payor Recommendations
The National Home Infusion Association (NHIA) has developed recommendations for commercial, Medicaid, and Medicare Advantage payors to improve patient outcomes and experience, reduce administrative burden, and improve timely access to home infusion services.
Rep. Dingell Touts Home Infusion Cost Savings in House Committee Meeting
This week, during a House Energy and Commerce Health Subcommittee hearing on Health Care Spending in the United States, Rep. Debbie Dingell (D-MI) addressed Medicare costs and the potential for home infusion to lead to significant cost savings.
Member Resource: Joe Fiandra Access to Home Infusion Act (H.R. 5397) Bill Summary
The Joe Fiandra Access to Home Infusion Act (H.R. 5397) was introduced in the House of Representatives in September of 2023, and mirrors a 2020 proposed rule from the Centers for Medicare and Medicaid Services (CMS) to modify the DMEPOS external infusion pump benefit. NHIA has developed a summary document for members explaining the bill.
Representatives Dingell, Harshbarger Advocate for NHIA Home Infusion Bill During Key Health Panel Markup
In a November 15 House Energy and Commerce Committee markup, Representative Debbie Dingell (D-MI) expressed frustration that the Preserving Patient Access to Home Infusion Act (H.R. 4104) was not among the 21 health care bills being considered as part of the session.
NHIA Responds to Congressional Committees’ Requests for Information (RFIs)
NHIA recently submitted comments to 2 Congressional committees seeking more information on health care-related issues, sharing its recommendations to modernize and personalize the health care system, support innovation, and increase patient access to quality and affordable care.